Articles About NYSE:TEVA
March 03, 2014
Teva may find its new formula of Copaxone is a tough sell for insurers; the company is desperate to convert patients.
February 10, 2014
A U.S. attorney is investigating documents regarding the sales and marketing of two different drugs made by Teva for possible false claims.